Asian Spectator

Men's Weekly

.

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

  • Written by PR Newswire Asia - Asian Spectator
  • PYC has developed a new drug candidate for the >5 million people worldwide[1] with Polycystic Kidney Disease (PKD)
  • This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2]
  • PKD is a life-changing disease affecting 1 in every 1,000 people[3]
  • Half of the patient...

More Articles ...

  1. Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Magazine

Diam seribu kata, fans tetap setia: Fenomena artis ‘tone-deaf’ soal Gaza Palestina

Taylor Swift sebagai artis yang sering kali disebut tone-deaf terkait isu Gaza PalestinaFigurnyi/Shuttershock● Beberapa artis kebal hujatan meski tone-deaf soal Gaza Palestina● Penggemar m...

‘Brain rot’ mudah menimpa anak dan remaja karena konten serba cepat

● Popularitas ‘Italian brain rot’ mencerminkan pergeseran preferensi digital generasi muda.● Paparan konten digital secara berlebihan berdampak negatif pada fokus, regulasi emo...

Riset: Kendaraan listrik hanya bisa benar-benar turunkan emisi jika bauran energi terbarukan tumbuh di atas 65% per tahun

● EV tidak otomatis menurunkan emisi.● Tanpa transisi ke energi terbarukan, kendaraan listrik hanya memindahkan emisi dari kendaraan ke pembangkit listrik.● Untuk menjadi solusi tran...